Literature DB >> 24502885

Hydrogen-rich saline attenuates postoperative liver failure after major hepatectomy in rats.

Yun Chang Tan1, Feng Xie2, Hui Lu Zhang3, Yu Li Zhu4, Ke Chen5, Hua Min Tan5, Ben Shun Hu5, Jia Mei Yang6, Jing Wang Tan7.   

Abstract

BACKGROUND/AIMS: A major hepatectomy occasionally lead to acute liver failure and death. We demonstrated the anti-oxidative and anti-inflammatory effects and functional mechanisms of hydrogen-rich saline (HS), a novel antioxidant, on an experimental model of rats after a partial hepatectomy (PH).
METHODS: The rats underwent a 90% hepatectomy. HS was given intraperitoneally after the operation and every 8hours after.
RESULTS: HS markedly improved the survival rate of two experimental groups after the massive hepatectomy and inhibited increases in serum levels of TBIL, DBIL, ALT and AST. The histopathological analysis demonstrated that HS attenuated inflammatory changes in the liver. HS administration markedly lowered the massive hepatectomy induced elevation of the serum hyaluronic acid (HA) concentrations. HS inhibited the formation of one of the markers of oxidative damage, malondialdehyde (MDA), and increased the activities of superoxide dismutase (SOD) in liver tissue. In the HS-treated group, increases in inflammatory cytokines, such as TNF-α, IL-6 and HMGB-1, were inhibited in the liver tissue. The NF-κB p65 staining revealed that HS inhibited the activation of the transcription factor nuclear factor kappa B (NF-kB).
CONCLUSIONS: HS attenuates the massive hepatectomy induced liver injury not only by attenuating oxidative damage, but also by reducing the production of inflammatory cytokines, such as TNF-α, IL-6 and HMGB-1, in part through the inhibition of NF-kB activation.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24502885     DOI: 10.1016/j.clinre.2013.11.007

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  7 in total

Review 1.  Hydrogen treatment: a novel option in liver diseases.

Authors:  Jian Shi; Brittany Duncan; Xuyuan Kuang
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

2.  Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles.

Authors:  Masatoshi Ichihara; Sayaka Sobue; Mikako Ito; Masafumi Ito; Masaaki Hirayama; Kinji Ohno
Journal:  Med Gas Res       Date:  2015-10-19

3.  Hydrogen-rich saline attenuates spinal cord hemisection-induced testicular injury in rats.

Authors:  Li Ge; Li-Hua Wei; Chang-Qing Du; Guo-Hua Song; Ya-Zhuo Xue; Hao-Shen Shi; Ming Yang; Xin-Xin Yin; Run-Ting Li; Xue-Er Wang; Zhen Wang; Wen-Gang Song
Journal:  Oncotarget       Date:  2017-06-27

Review 4.  Molecular hydrogen: a preventive and therapeutic medical gas for various diseases.

Authors:  Li Ge; Ming Yang; Na-Na Yang; Xin-Xin Yin; Wen-Gang Song
Journal:  Oncotarget       Date:  2017-09-21

Review 5.  Hydrogen: An Endogenous Regulator of Liver Homeostasis.

Authors:  Yaxing Zhang; Jingting Xu; Hongzhi Yang
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

Review 6.  Hydrogen, a Novel Therapeutic Molecule, Regulates Oxidative Stress, Inflammation, and Apoptosis.

Authors:  Yan Tian; Yafang Zhang; Yu Wang; Yunxi Chen; Weiping Fan; Jianjun Zhou; Jing Qiao; Youzhen Wei
Journal:  Front Physiol       Date:  2021-12-20       Impact factor: 4.566

7.  Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer.

Authors:  Ji-Bing Chen; Xiao-Feng Kong; Feng Mu; Tian-Yu Lu; You-Yong Lu; Ke-Cheng Xu
Journal:  Med Gas Res       Date:  2020 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.